Symrise AG has bought a minority in Bonumose, an early-stage food ingredient manufacturer specializing in the affordable production of delicious, good-for-you rare monosaccharides (alternatives to sucrose) such as tagatose and allulose. With this strategic transaction, Symrise will accelerate growth in its sugar reduction solutions. The area represents a high-priority focus for Symrise particularly the North America region within the Taste, Nutrition & Health segment.
Nick Russell, Senior Vice President – Business Incubation Group, Symrise AG said, “This exciting investment forges a strategic partnership. It will enhance our flavor and taste balancing technologies with Bonumose’s innovative and economical tagatose and other alternative sweetening solutions. Combining our technologies, will enable us to offer our customers new pathways to sugar reduction and taste balancing solutions. In turn, this will allow them to reduce sugar while optimizing the taste of better-for-you products for their consumers. This applies especially in the beverage and ice-cream categories. Health forms a growing focus category for Symrise. With the support of Bonumose’s enzymatic expertise, we can bring novel and disrupting ingredients to the marketplace together.”
Earlier this year, Bonumose opened a new R&D facility and manufacturing plant for its growing portfolio of sugar alternatives. Formed in 2016, Bonumose continues to grow thanks to their patented enzymatic technology which allows for the sustainable bulk production of healthy ingredients from globally-abundant plant material.
Ed Rogers, Bonumose CEO and Co-Founder said, “We feel enthusiastic about the future and the growth that the investment and partnership with Symrise enables. Now, we are coupling our expertise in tagatose and other naturally-occurring sugar alternatives with the extensive Symrise flavor proficiency and expansive portfolio across multiple platforms in both human food and animal nutrition. This creates the opportunity to offer unique value to customers. The strength of Symrise as an augmented flavor house paired with Bonumose’s patented enzymatic technology will enable cutting edge solutions to sugar reduction.”
